Showing results (151-160 of 302) with videos related to
Sort By:
Pageof 31
European Journal of Cancer (Oxford, England : 1990)|August 1, 2025
Sex-specific survival in advanced metastatic melanoma - a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREGAnna-Sophia Leven, Triinu Peters, Luisa Sophie Rajcsanyi, et al.European Journal of Cancer (Oxford, England : 1990)|October 23, 2017
Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitisCindy Franklin, Isabelle Rooms, Melanie Fiedler, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 1, 2026
Perioperative PD-1-inhibition in melanoma patients - a retrospective analysis from eight German skin cancer centersNina Flatt, Corinna Kochanek, Yenny Angela, et al.European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patientsSimone M Goldinger, Lisa Zimmer, Carsten Schulz, et al.Frontiers in Oncology|September 12, 2022
COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment: A prospective singlecenter study investigating seroconversion ratesGeorg C Lodde, Melanie Fiedler, Ulf Dittmer, et al.European Journal of Cancer (Oxford, England : 1990)|August 12, 2019
Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanomaTheodora Kanaki, Andreas Stang, Ralf Gutzmer, et al.ESC Heart Failure|July 27, 2022
Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapyJulia Pohl, Matthias Totzeck, Raluca-I Mincu, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2013
TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomasKlaus G Griewank, Bastian Schilling, Rajmohan Murali, et al.Cardio-Oncology (London, England)|June 17, 2026
Cardiac dysfunction during immune checkpoint inhibitor therapy: association with extracardiac immune-related adverse eventsRaluca I Mincu, Lena Lampe, Lars Michel, et al.British Journal of Cancer|April 9, 2026
Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarkerElena Sophia Lindner, Jakob Admard, German Demidov, et al.Pageof 31